| 000 | 01326 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512004525.0 | ||
| 264 | 0 | _c19891101 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-198910000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuckner, J C | |
| 245 | 0 | 0 |
_aEvaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cOct 1989 |
||
| 300 |
_a384-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDaunorubicin _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMenogaril |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNogalamycin _xadverse effects |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 700 | 1 | _aEdmonson, J H | |
| 700 | 1 | _aIngle, J N | |
| 700 | 1 | _aSchaid, D J | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 12 _gno. 5 _gp. 384-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-198910000-00004 _zAvailable from publisher's website |
| 999 |
_c2535726 _d2535726 |
||